Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Watchman21on Apr 16, 2022 8:50pm
125 Views
Post# 34607988

RE:RE:RE:New Breathalyzer Test

RE:RE:RE:New Breathalyzer TestHere's an article on the breathalyzer test


ABC news: https://abcnews.go.com/amp/Health/fda-authorizes-1st-covid-19-breathalyzer-test/story?id=84099986

 

TESTS/DAY:  160 tests a day per device


TEST TIME:   Roughly 3 minutes per test, add 2 minutes for cleanup, prep for next test …. That’s 12 tests per hour.  14 hours a day is 160-168 

PRODUCTION:  10 devices now, ramp up to 100 per week


COST:   $25,000-30,000 lease per month

 

DIRECT FROM ARTICLE

While this test offers rapid results -- promised in under three minutes -- this is not the same kind of rapid test available for purchase at local pharmacies. It is not aimed at being an "at-home" screening method -- rather, it is meant for what InspectIR Systems COO John Redmond described to ABC News as a "volume play."

 

InspectIR Systems aims to produce roughly 100 test devices per week, with 10 made so far, Kaiser told ABC News. In the next month, they expect to have roughly 250 test devices ready to go and say they will be making "as many as the line can hold."

 

Redmond said the company expects leasing agreements to cost between $25,000 and $30,000 per month

 

Each device can each be used to evaluate approximately 160 samples per day. 

 

ABC news: https://abcnews.go.com/amp/Health/fda-authorizes-1st-covid-19-breathalyzer-test/story?id=84099986

 

Facts:  160 tests a day per device

Time:   Roughly 3 minutes per test, add 2 minutes for cleanup, prep for next test …. That’s 12 tests per hour.  14 hours a day is 160-168 

Production:  10 devices now, ramp up to 100 per week

Cost:   $25,000-30,000 lease per month

 

 

While this test offers rapid results -- promised in under three minutes -- this is not the same kind of rapid test available for purchase at local pharmacies. It is not aimed at being an "at-home" screening method -- rather, it is meant for what InspectIR Systems COO John Redmond described to ABC News as a "volume play."

 

InspectIR Systems aims to produce roughly 100 test devices per week, with 10 made so far, Kaiser told ABC News. In the next month, they expect to have roughly 250 test devices ready to go and say they will be making "as many as the line can hold."

 

Redmond said the company expects leasing agreements to cost between $25,000 and $30,000 per month

 

Each device can each be used to evaluate approximately 160 samples per day.

<< Previous
Bullboard Posts
Next >>